Laboratory Fee Schedule
Procedure: MAM0089A
CPT: 86790


Synonym(s): Detection of IgM Antibodies to Zika Virus by Immunochromatographic Assay (ICA), Chembio Dual Path Platform (DPP) Assay System. Rapid point-of-care diagnostic test.
Requisition Form G-2V
Test Description Qualitative Immunochromatographic Assay (ICA) for the presumptive detection of IgM antibodies to Zika virus using Chembio DPP Assay system..
Pre-Approval Needed N/A
Supplemental Information Required N/A
Supplemental Form(s) N/A
Performed on Specimens from (sources) Human
Sample/Specimen Type for Testing Serum
Minimum Volume/Size Required 1.0 mL
Storage/Preservation Prior to Shipping Serum separated from the clot may be stored at 2°C to 8°C up to 48 hours, but then must be frozen at -20°C or colder until shipped.
Transport Medium N/A
Specimen Labeling At least 2 patient specific identifiers: First and last name as one identifier and a DOB or a unique patient specific identifier (e.g. Medical Record number); must match information on submission form (G-2A).
Shipping and Specimen Handling Requirements
  • Ship according to Dangerous Goods Regulations, IATA, and/or CFR 49.
  • Handle as infectious agent using universal precautions.
  • Triple contain in accordance with federal shipping regulations for infectious agents.  
    Additional forms & resources
Method ICA, lateral flow test, rapid test
Turn-around Time 7 working days
Interferences/Limitations Most common cause of false positive results is cross-reactivity with IgM specific for other flaviviruses. 
Common Causes for Rejection Insufficient quantity, unacceptable specimen type or source, improper shipping conditions, expired media or collection container, discrepancies between specimen label and submission form, and/or incomplete or missing submission form.
Additional Information Minimum volume for CDC confirmation testing 0.5 mL.